Relmada Therapeutics, Inc. (RLMD)
6.49
+0.11
(+1.72%)
USD |
NASDAQ |
Jun 11, 13:05
Relmada Therapeutics EPS Diluted (TTM) : -1.112 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.112 |
| December 31, 2025 | -1.470 |
| September 30, 2025 | -1.797 |
| June 30, 2025 | -2.213 |
| March 31, 2025 | -2.504 |
| December 31, 2024 | -2.652 |
| September 30, 2024 | -2.869 |
| June 30, 2024 | -2.880 |
| March 31, 2024 | -3.132 |
| December 31, 2023 | -3.282 |
| September 30, 2023 | -3.707 |
| June 30, 2023 | -4.287 |
| March 31, 2023 | -4.780 |
| December 31, 2022 | -5.306 |
| September 30, 2022 | -5.847 |
| June 30, 2022 | -6.973 |
| March 31, 2022 | -7.196 |
| December 31, 2021 | -7.136 |
| September 30, 2021 | -6.615 |
| June 30, 2021 | -5.231 |
| March 31, 2021 | -4.400 |
| December 31, 2020 | -3.783 |
| September 30, 2020 | -2.926 |
| June 30, 2020 | -2.231 |
| March 31, 2020 | -2.620 |
| Date | Value |
|---|---|
| June 30, 2019 | -2.973 |
| March 31, 2019 | -3.617 |
| December 31, 2018 | -4.300 |
| September 30, 2018 | -3.625 |
| June 30, 2018 | -2.868 |
| March 31, 2018 | -2.32 |
| December 31, 2017 | -1.92 |
| September 30, 2017 | -1.84 |
| June 30, 2017 | -2.08 |
| March 31, 2017 | -2.663 |
| December 31, 2016 | -2.623 |
| September 30, 2016 | -3.143 |
| June 30, 2016 | -1.143 |
| March 31, 2016 | 2.202 |
| December 31, 2015 | 1.802 |
| September 30, 2015 | 4.282 |
| June 30, 2015 | -11.76 |
| March 31, 2015 | -14.00 |
| December 31, 2014 | -13.50 |
| September 30, 2014 | -15.11 |
| February 28, 2014 | -0.5244 |
| September 30, 2013 | -0.5258 |
| August 31, 2013 | -0.0364 |
| May 31, 2013 | -0.0352 |
| February 28, 2013 | -0.0222 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Theravance Biopharma, Inc. | 2.205 |
| Indivior Pharmaceuticals, Inc. | 1.974 |
| ANI Pharmaceuticals, Inc. | 3.942 |
| Corcept Therapeutics, Inc. | 0.35 |
| Assertio Holdings, Inc. | -5.733 |